Myriad Genetics · 20 hours ago
VP Technology Transfer
United States
Full-time
Remote
Director/Executive
10+ years expMyriad Genetics is a company focused on translating scientific breakthroughs into life-changing diagnostics. The VP Technology Transfer will lead the newly established team responsible for turning late-stage R&D innovations into validated clinical products, ensuring compliance and operational efficiency throughout the process.
BiotechnologyPharmaceuticalPrecision Medicine
Responsibilities
Build and lead Myriad’s first Technology Transfer organization, responsible for operationalizing new assays and platforms from late-stage R&D into production
Define and implement transfer governance, documentation standards, and success metrics
Lead cross-functional programs that align R&D, Quality, Regulatory, Operations, and Commercial on launch readiness
Oversee design transfer, process validation, and workflow optimization for new products
Ensure compliance with CLIA, CAP, FDA, and ISO design control requirements
Develop a world-class team of scientists, engineers, and project leads (6–7 within 18 months)
Drive continuous improvement using Lean or Six Sigma principles to shorten transfer timelines
Champion a culture that connects scientific rigor with patient impact
Qualification
Required
Advanced degree in Molecular Biology, Biochemistry, Biomedical Engineering, or related discipline
10+ years of experience in molecular diagnostics, biotechnology, or clinical lab operations
Proven leadership of technology transfer, assay validation, or regulated product design control
Strong cross-functional leadership with R&D, Quality, Regulatory, and Operations
Working knowledge of CLIA, CAP, and ISO13485 standards
Experience scaling molecular assays or automation systems in a production environment
Passion for building teams and turning innovation into operational reality
Preferred
MS or PhD in Molecular Biology, Biochemistry, Biomedical Engineering, or related discipline
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
1001-5000 employees
H1B Sponsorship
Myriad Genetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (9)
2023 (4)
2022 (7)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
Company data provided by crunchbase